During the past decade, UW Cancer Center Johnson Creek conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 60 clinical trials were completed, i.e. on average, 117.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 33 clinical trials were completed. i.e. 235.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UW Cancer Center Johnson Creek" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UW Cancer Center Johnson Creek" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "UW Cancer Center Johnson Creek" are "Breast Cancer" (7 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "UW Cancer Center Johnson Creek" in a lesser frequency.

Most popular intervention types in "UW Cancer Center Johnson Creek" are "Drug" (85 trials), "Other" (69 trials), "Biological" (54 trials), "Radiation" (31 trials) and "Procedure" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (27 trials), "Cisplatin" (14 trials), "Questionnaire Administration" (14 trials) and "Nivolumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "UW Cancer Center Johnson Creek" are 92 trials for "All" genders, 11 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "UW Cancer Center Johnson Creek". undefined are not yet recruiting, 17 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in UW Cancer Center Johnson Creek, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UW Cancer Center Johnson Creek, 2 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".